KAI Pharmaceuticals VP of Finance Salaries in Boulder | Comparably
KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
89

KAI Pharmaceuticals VP of Finance Salaries in Boulder

The average KAI Pharmaceuticals VP of Finance in Boulder earns an estimated $157,326 annually. KAI Pharmaceuticals' VP of Finance compensation is $49,204 less than the US average for a VP of Finance.

In Boulder, The Finance Department at KAI Pharmaceuticals earns $5,328 more on average than the Operations Department.

Last updated 5 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$157,326
Average Compensation
$157,326
avg. base

VP of Finance Salaries at KAI Pharmaceuticals

In Boulder, VPs of Finance earn $64,064 more than Accounting Managers.

Accounting Manager
$93k*
Senior Accountant
$93k*
Business Analyst
$80k*
Financial Analyst
$75k*
Accountant
$67k*
* estimated salary

Compensation at KAI Pharmaceuticals by Department

In Boulder, The Finance Department averages $5,328 more than the Operations Department, and $15,618 less than the Sales Department

Sales
$92,176 Avg. total comp.
+$16k
Finance
$76,558 Avg. total comp.
Operations
$71,230 Avg. total comp.
-$5k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to KAI Pharmaceuticals reported making $188,034, while the average male VP of Finance at similar sized companies reported making $216,094.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to KAI Pharmaceuticals reported making $207,596, while the average Hispanic or Latino VP of Finance at similar sized companies reported making $170,500.

How VPs of Finance at KAI Pharmaceuticals Rate Their Compensation

The majority of VPs of Finance at KAI Pharmaceuticals believe they're compensated fairly. 100% of VPs of Finance at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals

×
Rate your company